HealthDay - MONDAY, July 13 (HealthDay News) -- Men with aggressive prostate cancer who have brachytherapy alone are more likely to die than those who receive a combination of treatments, new findings show.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.